EVEREST GROUP, LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 378.8 USD | -0.63% |
|
+0.03% | +7.12% |
| May. 14 | Calliditas Therapeutics Partner Offers Nefecon in China; Shares Rise | MT |
| May. 14 | Everest Medicines Commercially Launches Kidney Disease Drug in China | MT |
Official Publications
| Slide show Q3 | CO | |
| 3rd quarter results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 4K | CO | |
| SEC Filing 4K | CO | |
| Dividends | CO | |
| SEC Filing 10Q-2 | CO | |
| SEC Filing 8K | CO | |
| Slide show half-year results | CO | |
| 1st-half-year results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 4K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 10Q-1 | CO | |
| Slide show Q1 | CO | |
| 1st quarter results | CO | |
| SEC Filing 8K | CO | |
| Proxy Statments | CO | |
| SEC Filing 10K | CO | |
| Slide show results | CO | |
| Annual results | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 8K | CO | |
| SEC Filing 4K | CO |
- Stock Market
- Equities
- EG Stock
- News Everest Group, Ltd.
- Official Publications